HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

EVP 1001-1

a cardiac-specific MR imaging contrast agent

Also Known As:

EVP-1001-1; EVP1001-1

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Metals: 20694
  - Heavy Metals: 3207
    - Manganese: 3248
      - EVP 1001-1: 2
- Elements: 18681
  - Heavy Metals: 3207
    - Manganese: 3248
      - EVP 1001-1: 2
  - Transition Elements: 3
    - Manganese: 3248
      - EVP 1001-1: 2

Experts

1.	Harnish, Phillip P: 2 articles (02/2006 - 10/2003)
2.	Li, Wei: 2 articles (02/2006 - 10/2003)
3.	Prasad, Pottumarthi V: 2 articles (02/2006 - 10/2003)
4.	Seoane, Peter R: 2 articles (02/2006 - 10/2003)
5.	Storey, Pippa: 2 articles (02/2006 - 10/2003)
6.	Chen, Qun: 1 article (02/2006)
7.	Fogelson, Laura: 1 article (02/2006)
8.	Harris, Kathleen R: 1 article (02/2006)
9.	Danias, Peter G: 1 article (10/2003)
10.	Edelman, Robert R: 1 article (10/2003)

Related Diseases

1.	Myocardial Infarction 02/01/2006 - "The persistent enhancement pattern revealed by MRI following EVP 1001-1 administration may be beneficial for identifying and characterizing myocardial infarction." 02/01/2006 - "To investigate the MRI characteristics of an intracellular manganese-based contrast agent, EVP 1001-1 (Eagle Vision Pharmaceutical Corp.), in a canine model of myocardial infarction. " 02/01/2006 - "Magnetic resonance imaging of myocardial infarction using a manganese-based contrast agent (EVP 1001-1): preliminary results in a dog model."
2.	Myocardial Ischemia (Ischemic Heart Diseases) 10/01/2003 - "To investigate the potential of a novel manganese-based magnetic resonance (MR) contrast agent, EVP 1001-1 for the evaluation of myocardial ischemia. "
3.	Infarction (Infarctions) 02/01/2006 - "In the infarct, the response to EVP 1001-1 was small or negligible (DeltaR1= 0.27 +/- 0.28 sec(-1)). "

Related Drugs and Biologics

1.	Manganese
2.	Contrast Media